City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.

The findings of this cohort study suggest that the incidence of pancreatic adenocarcinoma has increased among all age groups, whereas that of colorectal adenocarcinoma has increased among younger age ...

Journal of the National Comprehensive Cancer Network found significant disparities based on race, socioeconomic status, and ...

Researchers at City of Hope have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology ...

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Pancreatic cancer remains one of the most deadly malignancies, with nearly 52,000 deaths expected this year.  With limited therapeutic advances made i | Cancer ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment ...

The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients with technically resectable pancreatic ductal adenocarcinoma (PDAC) who ...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S.